Home › Funds › Lion Point Capital, LP › SRPT
Lion Point Capital, LP position in SRPT
SAREPTA THERAPEUTICS INC · Health Care
Lion Point Capital, LP reported holding 28,500 shares of SRPT (SAREPTA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$512K, representing 2.45% of its reported portfolio and ranking #16 among its reported holdings. Lion Point Capital, LP has disclosed SRPT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Lion Point Capital, LP's SRPT position evolved
Lion Point Capital, LP first disclosed a stake in SRPT in Q4 2025 at 28,500 shares (US$613K). The position peaked in Q1 2026 at 28,500 shares, worth US$620K. Across 3 filings, Lion Point Capital, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 28,500 shares valued at US$512K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 28.50K | $613.32K | New |
| Q1 2026 | 28.50K | $620.16K | Hold |
| Q2 2026 | 28.50K | $512.14K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SRPT and 13F data
SRPT (SAREPTA THERAPEUTICS INC) is a Health Care company. 12 other funds we track also report a position in SRPT — the largest reported positions include HIGHBRIDGE CAPITAL MANAGEMENT LLC (US$49.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SRPT
- HIGHBRIDGE CAPITAL MANAGEMENT LLC 52.31M sh · $49.27M · Q2 2026
More on Lion Point Capital, LP
FAQ
How long has Lion Point Capital, LP held SRPT?
Lion Point Capital, LP has disclosed SRPT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Lion Point Capital, LP's current position in SRPT?
As of Q2 2026, Lion Point Capital, LP holds 28.50K shares of SRPT (SAREPTA THERAPEUTICS INC), valued at $512.14K, representing 2.45% of its reported portfolio and ranking #16.
Has Lion Point Capital, LP been buying or selling SRPT?
In the latest 13F filing (Q2 2026), Lion Point Capital, LP held unchanged its position in SRPT. The position peaked in Q1 2026 at 28.50K shares.
Which other funds hold SRPT?
Other major institutional holders of SRPT include HIGHBRIDGE CAPITAL MANAGEMENT LLC, among 12 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.